Optiscan has been featured in Stockhead, The Australian, and 11 News Corp mastheads in an article highlighting ASX-listed companies driving innovation in Australian medical manufacturing.
The article showcases Optiscan as a standout example of Australian-made medical technology, with its world-first digital endomicroscopy platform developed and manufactured in Melbourne. Through cutting-edge devices like InForm™, Optiscan is enabling real-time, slide-free imaging at the cellular level—reshaping how pathology and surgery are performed in both clinical and research settings.
By manufacturing locally and exporting globally, Optiscan is helping position Australia as a leader in advanced health technology. The article notes:
“Optiscan’s global headquarters are in Mulgrave in the heart of the ever-expanding and dynamic Melbourne medtech/biotech hub.Here, we have ready access to a skilled workforce, close proximity to world class universities, and a slew of medtech consulting and manufacturing firms at our doorstep to partner with. We’re proud to be part of this vibrant Victorian ecosystem,” Dr. Camile Farah, Optiscan CEO.
Stockhead – Read the full article here.
The Australian – Read the full article here.
